IT PHARMA INNOVATING TECHNOLOGY PHARMA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

IT PHARMA INNOVATING TECHNOLOGY PHARMA Trademark

Serial Number: 79351124 • Registration: 7451867

IT PHARMA INNOVATING TECHNOLOGY PHARMA is a trademark filed by INSTITUTO DE TECNOLOGIA Y ESTETICA PHARMA, S.L. on June 6, 2022. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

INSTITUTO DE TECNOLOGIA Y ESTETICA PHARMA, S.L. (2 trademarks)

Ciudad del Transporte, c/ Olite, 9

Entity Type: 87

Trademark Details

Filing Date

June 6, 2022

Registration Date

July 23, 2024

Published for Opposition

May 7, 2024

Goods & Services

Sanitary preparations for medical use; medical products, namely, liquid pharmaceutical treatments for acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; leaflet pharmaceutical treatments for acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; medicated cosmetic solutions in ampoules for acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; medicated cosmetic solutions in vials for acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; pharmaceutical preparations and substances for treating or prevention of acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; sanitary preparations for medical purposes, and products thereof, namely, liquid treatments for acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; leaflet treatments for acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; antioxidant solution in spray being food supplements; chemical preparations for sanitary use; medicinal hair lotions; injectable pharmaceutical products for treating or prevention of acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; injectable sanitary preparations products for medical use; medicinal creams for skin care; medicinal lotions for skin care; pharmacological pharmaceutical preparations for skin care; medical and pharmaceutical preparations, for application by means of medical devices, namely, for treating or prevention of acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; pharmaceutical products for treating or prevention of acne, cellulite, scars, skin aging, stretch marks, dark circles, droopy eyelids, sagging skin, alopecia, and blood circulation problems; dietetic substances in the nature of liquid treatments, leaflet treatments, medicated cosmetic solutions in ampoules, medicated cosmetic solutions in vials, and antioxidant solution in spray for medical use; dietetic foods for medical use; food for babies; dietetic supplements for humans.

Cosmetics; non-medicinal toiletries; essential oils; non-medicinal hair lotions; cosmetic lotions for skin care; non-medicated essences for skin care; non-medicated preparations for skin care; beauty masks; body mask lotions for cosmetic use; skin care creams other than for medical use; tissues impregnated with cosmetic preparations; cosmetic preparations for slimming; cosmetic preparations for topical use; cosmetics for wrinkle treatment

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 29, 2025 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Jan 27, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 27, 2025 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 23, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 23, 2024 R.PR
NOTIFICATION PROCESSED BY IB
May 7, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 7, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 17, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 17, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 1, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 1, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 1, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 1, 2024 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 25, 2024 OPNX
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 15, 2024 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 6, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 6, 2024 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 7, 2023 GNFN
FINAL REFUSAL E-MAILED
Dec 7, 2023 GNFR
FINAL REFUSAL WRITTEN
Dec 7, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 5, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 5, 2023 TROA
REFUSAL PROCESSED BY IB
Jun 26, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 6, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jun 6, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 8, 2023 RFCR
NON-FINAL ACTION WRITTEN
Apr 7, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 4, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 30, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 29, 2022 REPR